Randomized Arthrex Nano Arthroscopy in Arthroscopic ACL vs Conventional Arthroscopy

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-60
SponsorUniversity of Colorado, Denver

About this trial

The study is a pilot study designed to generate preliminary data regarding the cost of ACL surgery using NanoScope versus conventional arthroscopy in a traditional operating room (OR) setting.

Eligibility criteria

Qualifiers

Subject is 18 - 60 years of age.

Subject body mass index (BMI) is 40 or lower (BMI ≤ 40).

Subject signed informed consent and is willing and able to comply with all study requirements and follow-up visits.

Confirmed ACL injury by MRI and physical exam as per standard of care.

Disqualifiers

Revision ACL case.

Current bilateral knee injury.

Insufficient quantity or quality of bone.

Blood supply limitations and previous infections which may retard healing.

Trial design

Treatments tested in this trial

  • ACL surgery using Arthrex NanoScope
  • ACL surgery using conventional arthroscopy

Treatment groups

42 Participants
are divided into 2 treatment groups

Locations

This trial has no locations

Sponsors and collaborators